MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Implementation of the Parkinson’s Disease-Health Index (PD-HI), a Novel, Validated, Disease-Specific Patient-Reported Outcome Measure, in a 24-Month Natural History Study

    J. Purks, J. Seabury, J. Weinstein, A. Varma, S. Rosero, C. Engebrecht, C. Irwin, C. Shupe, A. Arky, J. Heatwole, C. Zizzi, N. Dilek, J. Adams, E. Dorsey, C. Heatwole (Rochester, USA)

    Objective: To evaluate and optimize the relevance, usability and longitudinal responsiveness of the Parkinson’s Disease-Health Index (PD-HI) for use in PD clinical trials. Background: The…
  • 2024 International Congress

    Development of a National Initiative for the Professionalization of Parkinson Nurses – Results from Germany

    M. van Munster, J. Stümpel, O. Fründt, A. Becker, T. Warnecke, C. Eggers, T. Mestre, T. Clemens, K. Czabanowska (Marburg, Germany)

    Objective: To describe the development of the profession Parkinson Nurse in Germany resulting from a 3-year research process. Background: The profession of specialized Parkinson Nurses…
  • 2024 International Congress

    Masticatory function evaluation methods in movement disorders

    Y. Navarrete Cortés, P. Castelo, L. Feitosa, G. Azevedo Diaféria, A. Said, C. Ribeiro Neves, O. Barsottini, S. Bommarito (São Paulo, Brazil)

    Objective: To characterize masticatory function in individuals with Parkinson's Disease (PD) and Spinocerebellar Ataxia (SCA3) regarding the orofacial myofunctional condition (OMES-E), the masticatory performance and…
  • 2024 International Congress

    Impact of Community Boxing Program on Non-motor Symptoms in Individuals with Parkinson’s Disease

    M. Braitsch, S. Shearin, R. Querry, E. Perez (Richardson, USA)

    Objective: The purpose of this intervention was to assess the impact of boxing on non-motor symptoms (NMS) in PD. Background: ​​​​​​For persons with Parkinson’s Disease…
  • 2024 International Congress

    Incidence of Depression in the Caregivers of Parkinson’s Disease Patients

    S. Soleimani, M. Salari, F. Hojjati Pour (Tehran, Islamic Republic of Iran)

    Objective: To evaluate the impact of caring for individuals with Parkinson's disease on caregivers' social activities and mental health, and to assess depression and quality…
  • 2024 International Congress

    Palliative and end-of-life care in Parkinson’s disease : French patients’ perceptions and knowledge

    M. Auffret, L. Cronier, G. Robert, M. Béreau, M. Giffard, M. Vérin (Rennes, France)

    Objective: (1) Assess patients' perceptions and knowledge of palliative and end-of-life care in PD; (2) evaluate (i) whether patients discuss these topics with healthcare professionals and/or…
  • 2024 International Congress

    A Prospective, Multicenter, Single-Arm Feasibility Study Examining ECAP-Controlled, Closed-Loop Spinal Cord Stimulation for Parkinson’s Disease (eCAP-PD): Technical and Design Considerations

    L. Verhagen, T. Virmani, M. Pourfar, C. Hess, J. Rosenow, E. Petersen, A. Mogilner, J. Karl, N. Shetty (Chicago, USA)

    Objective: Conduct a prospective feasibility study to determine the effects of ECAP-controlled closed-loop spinal cord stimulation (SCS) on motor symptoms in Parkinson’s disease (PD) patients.…
  • 2024 International Congress

    Efficacy of Opicapone and Levodopa with Different Levodopa Daily Doses in Parkinson’s Disease Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

    Objective: To evaluate the effect of opicapone (OPC) 50 mg versus an additional levodopa (L-DOPA) dose of 100 mg in patients with Parkinson’s disease (PD)…
  • 2024 International Congress

    Assessing a Video Based Approach at Measuring Parkinson’s Disease Severity – A Validation Study

    BP. Bridges (St. John's, Canada)

    Objective: To validate the Parkinson’s remote interactive monitoring system’s assessment of Parkinson’s disease compared to a clinical assessment completed by a movement disorder specialist. Background:…
  • 2024 International Congress

    Remote recruitment of hyposmic participants identifies biomarkers related to neuronal alpha-synuclein disease

    E. Brown, A. Siderowf, T. Simuni, T. Sherer, M. Brumm, C. Caspell-Garcia, R. Kurth, C. Gochanour, M. Marshall, M. Korell, C. Stanley, L. Concha, C. Soto, K. Marek, C. Tanner (San Francisco, USA)

    Objective: To evaluate the proportion of people with dopaminergic deficit and positive alpha-synuclein seed amplification assay (aSyn SAA) among a remotely identified group of hyposmic…
  • « Previous Page
  • 1
  • …
  • 186
  • 187
  • 188
  • 189
  • 190
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley